查看购物车
  • Traditional Chinese
  • English
2021-2031年亚太地区类器官市场报告：范围、细分、动态与竞争分析
市场调查报告书
商品编码
1871518

2021-2031年亚太地区类器官市场报告：范围、细分、动态与竞争分析

Asia Pacific Organoids Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 261 Pages | 订单完成后即时交付

价格

预计亚太地区类器官市场将显着成长，到 2031 年将达到约 23.271 亿美元，高于 2023 年的 4.1914 亿美元，预测期内年复合成长率(CAGR) 高达 23.9%。

执行摘要和市场分析

亚太地区的类器官市场涵盖澳洲、中国、印度、日本、韩国等国。由于癌症发病率上升、对基因突变和癌症研究的需求增加、政府为提高公众对人类类器官的认知而采取的倡议、有利于先进类器官产品开发和商业化的法规以及对类器官研究投入的增加等多种因素，预计该市场将快速增长。

市场区隔分析

亚太地区类器官市场可按类型、应用、来源、产品和方法进行细分：

  • 类型：市场依类器官类型分为肠道、肝臟、胃、胰臟、肺、脑、肾臟等。 2023年，肠道类器官占了最大的市场。
  • 应用领域：主要应用包括发育生物学疾病、传染病病理学、再生医学、药物毒性和疗效测试、药物研发以及个人化医疗。 2023年，发育生物学疾病领域占最大份额。
  • 资料来源：市场分为多能干细胞和器官特异性成体干细胞，其中多能干细胞在 2023 年占据市场份额的主导地位。
  • 产品/服务：此部分包括仪器、耗材和服务，其中耗材在 2023 年占据市场主导地位。仪器又分为设备和仪器，而耗材包括感测器和其他物品。
  • 方法：类器官发育所采用的方法包括微图案板、超低附着板、悬滴法、微滴法或乳液法等，其中悬滴法在2023年占据最大份额。

市场展望

个人化医疗，或称精准医疗，是一种日益流行的趋势，它根据患者的特定反应或疾病风险，量身定制医疗方案。这一趋势正显着推动亚洲地区类器官技术的研发和应用。例如，在中国，精准生物技术有限公司（ACCURATE International Biotechnology）已建立起全球最大的肿瘤类器官平台之一，拥有超过5000个模型，用于针对特定患者的药物测试。与澳门大学等机构的合作，进一步推进了疾病建模和药物反应的研究。

在日本，九州大学和名古屋大学等高校正将人工智慧与类器官开发相结合，在筛选用于治疗的高品质类器官方面取得了很高的准确率。研究人员也正在探索基因编辑类器官在肝臟和神经系统疾病研究的应用。韩国2024年类器官开发者大会重点关注了再生医学应用，专家们探讨了类器官在溃疡性结肠炎等疾病治疗中的应用。新加坡正崛起为创新中心，Next&Bio与新加坡癌症科学研究所合作建立癌症类器官库，以开发更有效的肿瘤疗法，便是最好的例子。

药剂师在推广个人化医疗、提高公众对精准治疗的认知以及鼓励製药公司研发客製化疗法方面发挥着至关重要的作用。个人化癌症医疗专注于基于肿瘤基因组特征开发有效的治疗策略。由于肿瘤类器官能够准确预测药物反应，相较于传统模型具有显着优势，因此对个人化肿瘤建模的研究需求日益增长。

国家概况

亚太地区类器官市场涵盖日本、中国、印度、韩国、澳洲和东南亚等主要国家，其中中国在2023年占据最大的市场份额。中国市场的成长得益于研究的进步和个人化医疗的普及。肿瘤类器官的开发是一项重大突破，使研究人员能够研究受肿瘤影响的各种组织和器官。

诸如Hubrecht Organoid Technology与华大基因青岛株式会社的合作，旨在促进中国个人化医疗和治疗的发展。此外，干细胞研究经费的增加可望推动类器官的研发。

公司简介

类器官市场的主要参与者包括STEMCELL Technologies Inc.、Molecular Devices、Hubrecht Organoid Technology、Definigen、Organoid Therapeutics、Thermo Fisher Scientific、Corning、Merck KGaA、InSphero、ACRO Biosystems、Bio-Techne、SUN bioscience、ORGANOID SCIY Biologics、3Dnamics和Cellesce。这些公司正透过扩张、产品创新和併购等策略来增强其市场份额并提供创新解决方案。

目录

第一章：引言

第二章：执行概要

  • 关键见解

第三章：研究方法

  • 二手研究
  • 初步研究
    • 假设的提出：
    • 宏观经济因素分析：
    • 发展基础数字：
    • 数据三角测量：
    • 国家层面资料：

第四章：亚太地区类器官市场概况

  • PEST分析

第五章：亚太地区类器官市场－主要市场动态

  • 市场驱动因素
    • 对肿瘤建模和生物样本库的需求日益增长
    • 个人化药物的广泛应用
  • 市场限制
    • 缺乏熟练的专业人才
  • 市场机会
    • 重点关注药物发现活动
  • 未来趋势
    • 类器官与晶片器官的结合
  • 驾驶员和安全带的影响：

第六章：类器官市场－亚太地区分析

  • 2021-2031年亚太地区类器官市场收入
  • 亚太地区类器官市场预测分析

第七章：亚太地区类器官市场分析－依类型划分

  • 肠
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第八章：亚太地区类器官市场分析－依应用领域划分

  • 发育生物学疾病
  • 传染病病理学
  • 再生医学
  • 药物毒性和疗效测试
  • 药物发现与个人化医疗
  • 其他的

第九章：亚太地区类器官市场分析－依来源划分

  • 多能干细胞
  • 器官特异性成体干细胞

第十章：亚太地区类器官市场分析－依产品/服务分类

  • 仪器
  • 消耗品
  • 服务

第十一章：亚太地区类器官市场分析－依方法划分

  • 微图案板
  • 超低附件板
  • 悬垂
  • 微滴或乳液
  • 其他的

第十二章：亚太地区类器官市场－国家分析

  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 新加坡
    • 泰国
    • 马来西亚
    • 越南
    • 印尼
    • 菲律宾
    • 亚太其他地区

第十三章：行业概况

  • 概述
  • 类器官市场成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十四章：公司简介

  • STEMCELL Technologies Inc
  • Molecular Devices, LLC.
  • Hubrecht Organoid Technology
  • Definigen
  • Organoid Therapeutics
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero
  • ACRO Biosystems.
  • Bio-Techne Corp
  • SUN bioscience SA
  • ORGANOID SCIENCES Co., Ltd.
  • Crown Bioscience Inc
  • Sartorius AG
  • 3D Biotek LLC
  • Prellis Biologics Inc.
  • 3Dnamics Inc.
  • Cellesce Ltd

第十五章：附录

Product Code: TIPRE00018852

The Asia Pacific organoids market is projected to grow significantly, reaching approximately US$ 2,327.10 million by 2031, up from US$ 419.14 million in 2023, with a remarkable compound annual growth rate (CAGR) of 23.9% during the forecast period.

Executive Summary and Market Analysis

The organoids market in the Asia Pacific region includes countries such as Australia, China, India, Japan, South Korea, and others. The market is expected to expand rapidly due to several factors, including the rising incidence of cancer, increased demand for research on gene mutations and cancer, government initiatives to promote awareness of human organoids, supportive regulations for the development and commercialization of advanced organoid products, and heightened funding for organoid research.

Market Segmentation Analysis

The Asia Pacific organoids market can be segmented based on type, application, source, offering, and method:

  • Type: The market is divided into organoids from the intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2023, the intestine organoid segment held the largest market share.
  • Application: Key applications include developmental biology disease, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery, and personalized medicine. The developmental biology disease segment was the largest in 2023.
  • Source: The market is categorized into pluripotent stem cells and organ-specific adult stem cells, with pluripotent stem cells dominating the market share in 2023.
  • Offering: This segment includes instruments, consumables, and services, with consumables leading the market in 2023. Instruments are further divided into devices and equipment, while consumables include sensors and other items.
  • Method: The methods used in organoid development include micropatterned plates, ultralow attachment plates, hanging drop, microdroplet or emulsion, and others, with the hanging drop method holding the largest share in 2023.

Market Outlook

Personalized medicine, or precision medicine, is a growing trend that tailors medical treatments to individual patients based on their specific responses or disease risks. This trend is significantly driving the development and application of organoid technologies across Asia. For instance, in China, ACCURATE International Biotechnology has created one of the largest tumor organoid platforms globally, featuring over 5,000 models for patient-specific drug testing. Collaborations with institutions like the University of Macau have further advanced research in disease modeling and drug responses.

In Japan, universities such as Kyushu and Nagoya are integrating artificial intelligence with organoid development, achieving high accuracy in selecting quality organoids for therapeutic applications. Researchers are also exploring gene-edited organoids to investigate liver and neurological disorders. South Korea's 2024 Organoid Developer Conference highlighted regenerative medicine applications, with experts discussing organoid use in treating conditions like ulcerative colitis. Singapore is emerging as a hub for innovation, exemplified by Next&Bio's partnership with the Cancer Science Institute of Singapore to develop a cancer organoid bank for more effective oncology therapies.

Pharmacists are crucial in promoting personalized medicine, raising awareness about precision treatments, and encouraging pharmaceutical companies to create tailored therapies. Personalized cancer medicine focuses on developing effective treatment strategies based on the genomic profiles of tumors. The demand for research in personalized tumor modeling is increasing, as tumor organoids can accurately predict drug responses, offering significant advantages over traditional models.

Country Insights

The Asia Pacific organoids market includes key countries such as Japan, China, India, South Korea, Australia, and Southeast Asia, with China holding the largest market share in 2023. The growth in China is driven by advancements in research and the popularity of personalized medicine. The development of tumor organoids has been a significant breakthrough, allowing researchers to study various tissues and organs affected by tumors.

Collaborations, such as the one between Hubrecht Organoid Technology and BGI-Qingdao, aim to enhance personalized care and treatment development in China. Additionally, increasing funding for stem cell research is expected to boost organoid research and development.

Company Profiles

Key players in the organoids market include STEMCELL Technologies Inc., Molecular Devices, Hubrecht Organoid Technology, Definigen, Organoid Therapeutics, Thermo Fisher Scientific, Corning, Merck KGaA, InSphero, ACRO Biosystems, Bio-Techne, SUN bioscience, ORGANOID SCIENCES, Crown Bioscience, Sartorius, 3D Biotek, Prellis Biologics, 3Dnamics, and Cellesce. These companies are employing strategies such as expansion, product innovation, and mergers to enhance their market presence and offer innovative solutions.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Organoids Market Landscape

  • 4.1 PEST Analysis

5. Asia Pacific Organoids Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
    • 5.1.2 Surging Adoption of Personalized Drugs
  • 5.2 Market Restraints
    • 5.2.1 Dearth of Skilled Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Focus on Drug Discovery Activities
  • 5.4 Future Trends
    • 5.4.1 Combination of Organoids and Organ-on-a-Chip
  • 5.5 Impact of Drivers and Restraints:

6. Organoids Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Organoids Market Revenue (US$ Million), 2021-2031
  • 6.2 Asia Pacific Organoids Market Forecast Analysis

7. Asia Pacific Organoids Market Analysis - by Type

  • 7.1 Intestine
    • 7.1.1 Overview
    • 7.1.2 Intestine: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Liver
    • 7.2.1 Overview
    • 7.2.2 Liver: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Pancreas
    • 7.4.1 Overview
    • 7.4.2 Pancreas: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Lung
    • 7.5.1 Overview
    • 7.5.2 Lung: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Brain
    • 7.6.1 Overview
    • 7.6.2 Brain: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.7 Kidney
    • 7.7.1 Overview
    • 7.7.2 Kidney: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Organoids Market Analysis - by Application

  • 8.1 Developmental Biology Disease
    • 8.1.1 Overview
    • 8.1.2 Developmental Biology Disease: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Pathology of Infectious Disease
    • 8.2.1 Overview
    • 8.2.2 Pathology of Infectious Disease: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Regenerative Medicine
    • 8.3.1 Overview
    • 8.3.2 Regenerative Medicine: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Drug Toxicity and Efficacy Testing
    • 8.4.1 Overview
    • 8.4.2 Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Drug Discovery and Personalized Medicine
    • 8.5.1 Overview
    • 8.5.2 Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Organoids Market Analysis - by Source

  • 9.1 Pluripotent Stem Cells
    • 9.1.1 Overview
    • 9.1.2 Pluripotent Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Organ-Specific Adult Stem Cell
    • 9.2.1 Overview
    • 9.2.2 Organ-Specific Adult Stem Cell: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Organoids Market Analysis - by Offering

  • 10.1 Instruments
    • 10.1.1 Overview
    • 10.1.2 Instruments: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.2 Consumables
    • 10.2.1 Overview
    • 10.2.2 Consumables: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 10.3 Services
    • 10.3.1 Overview
    • 10.3.2 Services: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

11. Asia Pacific Organoids Market Analysis - by Method

  • 11.1 Micropatterned Plates
    • 11.1.1 Overview
    • 11.1.2 Micropatterned Plates: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.2 Ultralow Attachment Plates
    • 11.2.1 Overview
    • 11.2.2 Ultralow Attachment Plates: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.3 Hanging Drop
    • 11.3.1 Overview
    • 11.3.2 Hanging Drop: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.4 Microdroplet or Emulsion
    • 11.4.1 Overview
    • 11.4.2 Microdroplet or Emulsion: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)

12. Asia Pacific Organoids Market - Country Analysis

  • 12.1 Asia Pacific
    • 12.1.1 Asia Pacific Organoids Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 Asia Pacific Organoids Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.2 Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.2.1 Japan: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.2.2 Japan: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.2.3 Japan: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.2.4 Japan: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.2.5 Japan: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.2.6 Japan: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.2.7 Japan: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.3 China: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.3.1 China: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.3.2 China: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.3.3 China: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.3.4 China: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.3.5 China: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.3.6 China: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.3.7 China: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.4 India: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.4.1 India: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.4.2 India: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.4.3 India: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.4.4 India: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.4.5 India: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.4.6 India: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.4.7 India: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.5 South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.5.1 South Korea: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.5.2 South Korea: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.5.3 South Korea: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.5.4 South Korea: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.5.5 South Korea: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.5.6 South Korea: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.5.7 South Korea: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.6 Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.6.1 Australia: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.6.2 Australia: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.6.3 Australia: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.6.4 Australia: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.6.5 Australia: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.6.6 Australia: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.6.7 Australia: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.7 Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.7.1 Singapore: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.7.2 Singapore: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.7.3 Singapore: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.7.4 Singapore: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.7.5 Singapore: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.7.6 Singapore: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.7.7 Singapore: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.8 Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.8.1 Thailand: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.8.2 Thailand: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.8.3 Thailand: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.8.4 Thailand: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.8.5 Thailand: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.8.6 Thailand: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.8.7 Thailand: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.9 Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.9.1 Malaysia: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.9.2 Malaysia: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.9.3 Malaysia: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.9.4 Malaysia: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.9.5 Malaysia: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.9.6 Malaysia: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.9.7 Malaysia: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.10 Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.10.1 Vietnam: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.10.2 Vietnam: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.10.3 Vietnam: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.10.4 Vietnam: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.10.5 Vietnam: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.10.6 Vietnam: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.10.7 Vietnam: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.11 Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.11.1 Indonesia: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.11.2 Indonesia: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.11.3 Indonesia: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.11.4 Indonesia: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.11.5 Indonesia: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.11.6 Indonesia: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.11.7 Indonesia: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.12 Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.12.1 Philippines: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.12.2 Philippines: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.12.3 Philippines: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.12.4 Philippines: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.12.5 Philippines: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.12.6 Philippines: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.12.7 Philippines: Asia Pacific Organoids Market Share - by Method
      • 12.1.1.13 Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 12.1.1.13.1 Rest of APAC: Asia Pacific Organoids Market Share - by Type
        • 12.1.1.13.2 Rest of APAC: Asia Pacific Organoids Market Share - by Application
        • 12.1.1.13.3 Rest of APAC: Asia Pacific Organoids Market Share - by Source
        • 12.1.1.13.4 Rest of APAC: Asia Pacific Organoids Market Share - by Offering
        • 12.1.1.13.5 Rest of APAC: Asia Pacific Organoids Market Share - by Instruments
        • 12.1.1.13.6 Rest of APAC: Asia Pacific Organoids Market Share - by Consumables
        • 12.1.1.13.7 Rest of APAC: Asia Pacific Organoids Market Share - by Method

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Organoids Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 STEMCELL Technologies Inc
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Molecular Devices, LLC.
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Hubrecht Organoid Technology
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Definigen
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Organoid Therapeutics
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Thermo Fisher Scientific Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Corning Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Merck KGaA
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 InSphero
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 ACRO Biosystems.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 Bio-Techne Corp
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments
  • 14.12 SUN bioscience SA
    • 14.12.1 Key Facts
    • 14.12.2 Business Description
    • 14.12.3 Products and Services
    • 14.12.4 Financial Overview
    • 14.12.5 SWOT Analysis
    • 14.12.6 Key Developments
  • 14.13 ORGANOID SCIENCES Co., Ltd.
    • 14.13.1 Key Facts
    • 14.13.2 Business Description
    • 14.13.3 Products and Services
    • 14.13.4 Financial Overview
    • 14.13.5 SWOT Analysis
    • 14.13.6 Key Developments
  • 14.14 Crown Bioscience Inc
    • 14.14.1 Key Facts
    • 14.14.2 Business Description
    • 14.14.3 Products and Services
    • 14.14.4 Financial Overview
    • 14.14.5 SWOT Analysis
    • 14.14.6 Key Developments
  • 14.15 Sartorius AG
    • 14.15.1 Key Facts
    • 14.15.2 Business Description
    • 14.15.3 Products and Services
    • 14.15.4 Financial Overview
    • 14.15.5 SWOT Analysis
    • 14.15.6 Key Developments
  • 14.16 3D Biotek LLC
    • 14.16.1 Key Facts
    • 14.16.2 Business Description
    • 14.16.3 Products and Services
    • 14.16.4 Financial Overview
    • 14.16.5 SWOT Analysis
    • 14.16.6 Key Developments
  • 14.17 Prellis Biologics Inc.
    • 14.17.1 Key Facts
    • 14.17.2 Business Description
    • 14.17.3 Products and Services
    • 14.17.4 Financial Overview
    • 14.17.5 SWOT Analysis
    • 14.17.6 Key Developments
  • 14.18 3Dnamics Inc.
    • 14.18.1 Key Facts
    • 14.18.2 Business Description
    • 14.18.3 Products and Services
    • 14.18.4 Financial Overview
    • 14.18.5 SWOT Analysis
    • 14.18.6 Key Developments
  • 14.19 Cellesce Ltd
    • 14.19.1 Key Facts
    • 14.19.2 Business Description
    • 14.19.3 Products and Services
    • 14.19.4 Financial Overview
    • 14.19.5 SWOT Analysis
    • 14.19.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners

List Of Tables

  • Table 1. Asia Pacific Organoids Market Segmentation
  • Table 2. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Offering
  • Table 7. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Method
  • Table 8. Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 9. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 10. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 11. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 12. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 13. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 14. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 15. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 16. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 17. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 18. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 19. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 20. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 21. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 22. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 23. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 24. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 25. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 26. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 27. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 28. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 29. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 30. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 31. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 32. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 33. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 34. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 35. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 36. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 37. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 38. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 39. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 40. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 41. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 42. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 43. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 44. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 45. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 46. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 47. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 48. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 49. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 50. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 51. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 52. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 53. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 54. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 55. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 56. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 57. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 58. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 59. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 60. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 61. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 62. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 63. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 64. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 65. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 66. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 67. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 68. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 69. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 70. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 71. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 72. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 73. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 74. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 75. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 76. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 77. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 78. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 79. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 80. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 81. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 82. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 83. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 84. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 85. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 86. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 87. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 88. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 89. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Offering
  • Table 90. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Instruments
  • Table 91. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Consumables
  • Table 92. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Method
  • Table 93. Recent Organic Growth Strategies in Organoids Market
  • Table 94. Recent Inorganic Growth Strategies in the Organoids Market

List Of Figures

  • Figure 1. Asia Pacific Organoids Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Asia Pacific Organoids Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Asia Pacific Organoids Market Revenue (US$ Million), 2021-2031
  • Figure 6. Asia Pacific Organoids Market Share (%) - by Type (2023 and 2031)
  • Figure 7. Intestine: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Liver: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Stomach: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Pancreas: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Lung: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Brain: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Kidney: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Others: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Asia Pacific Organoids Market Share (%) - by Application (2023 and 2031)
  • Figure 16. Developmental Biology Disease: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Pathology of Infectious Disease: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Regenerative Medicine: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Others: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Asia Pacific Organoids Market Share (%) - by Source (2023 and 2031)
  • Figure 23. Pluripotent Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Organ-Specific Adult Stem Cell: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 25. Asia Pacific Organoids Market Share (%) - by Offering (2023 and 2031)
  • Figure 26. Instruments: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Consumables: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. Services: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 29. Asia Pacific Organoids Market Share (%) - by Method (2023 and 2031)
  • Figure 30. Micropatterned Plates: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 31. Ultralow Attachment Plates: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 32. Hanging Drop: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Microdroplet or Emulsion: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. Others: Asia Pacific Organoids Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Asia Pacific Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 36. Japan: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 37. China: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 38. India: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 39. South Korea: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 40. Australia: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 41. Singapore: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 42. Thailand: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 43. Malaysia: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 44. Vietnam: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 45. Indonesia: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 46. Philippines: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 47. Rest of APAC: Asia Pacific Organoids Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 48. Growth Strategies in Organoids Market